Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2023 Earnings Call Transcript October 30, 2023 Pacific Biosciences of California, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.3. Operator: Good afternoon, everyone, and welcome to the PacBio Third Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After […]
On October 16, 2023, Pacific Biosciences of California, Inc. disclosing that the Board of Directors of the Company appointed David Meline to serve as a Class II director, with an initial term.
Former CFO of Moderna, Amgen, and 3M Brings Decades of Relevant Experience to the PacBio Board
MENLO PARK, Calif., Oct. 16, 2023 /PRNewswire/ PacBio , a leading developer of high-quality, highly.
Pacific Bio (PACB) Appoints David Meline to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
4 Tech Stocks With Upside Potential and Dividend Yields Beating S&P 500 investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.